• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在处理儿童感染方面,基于培养的策略比经验性治疗策略更具成本效益。

A Culture-Based Strategy Is More Cost Effective Than an Empiric Therapy Strategy in Managing Pediatric Infection.

作者信息

Hung Chi-Wen, Chen Solomon Chih-Chen, Ku Li-Jung Elizabeth, Sheu Bor-Shyang, Yang Yao-Jong

机构信息

Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Department of Pediatrics and Institute of Clinical Medicine, National Cheng Kung University Hospital, Medical College, National Cheng Kung University, Tainan, Taiwan.

出版信息

Front Pediatr. 2022 May 3;10:860960. doi: 10.3389/fped.2022.860960. eCollection 2022.

DOI:10.3389/fped.2022.860960
PMID:35592847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9110685/
Abstract

BACKGROUND

infection is a major cause of peptic ulcers and gastric cancer. This study aimed to compare the eradication rate and essential costs of culture-based and empiric therapy strategies in treating pediatric infection.

METHODS

We retrospectively enrolled patients aged <18 years with a diagnosis of infection who received esophagogastroduodenoscopy at two medical centers in southern Taiwan from 1998 to 2018. Patients with positive cultures and minimum inhibitory concentration test results were allocated to a culture-based strategy, and those with negative cultures or without culture as an empiric therapy strategy. We collected demographic data and eradication rates, and calculated the total essential costs of treating a hypothetical cohort of 1,000 pediatric patients based on the two strategies.

RESULTS

Ninety-six patients were enrolled, of whom 55 received a culture-based strategy and 41 received an empiric therapy strategy. The eradication rates with the first treatment were 89.1 and 75.6% in the culture-based and empiric therapy strategy, respectively. There were no significant differences in age, sex, and endoscopic diagnosis between the two strategies. For every 10% increase in those receiving a culture-based strategy, the total cost would have been reduced by US$466 in a hypothetical cohort of 1,000 patients. For every 10% increase in successful eradication rate, the total cost was reduced by US$24,058 with a culture-based strategy and by US$20,241 with an empiric therapy strategy.

CONCLUSIONS

A culture-based strategy was more cost effective than an empiric therapy strategy in treating pediatric -infected patients.

摘要

背景

感染是消化性溃疡和胃癌的主要病因。本研究旨在比较基于培养的治疗策略和经验性治疗策略在治疗儿童感染方面的根除率和基本成本。

方法

我们回顾性纳入了1998年至2018年在台湾南部两个医疗中心接受食管胃十二指肠镜检查、年龄<18岁且诊断为感染的患者。培养结果为阳性且有最低抑菌浓度测试结果的患者被分配到基于培养的治疗策略组,培养结果为阴性或未进行培养的患者则采用经验性治疗策略。我们收集了人口统计学数据和根除率,并根据这两种策略计算了治疗1000名儿童患者这一假设队列的总基本成本。

结果

共纳入96例患者,其中55例接受基于培养的治疗策略,41例接受经验性治疗策略。在基于培养的治疗策略和经验性治疗策略中,首次治疗的根除率分别为89.1%和75.6%。两种策略在年龄、性别和内镜诊断方面无显著差异。在1000名患者的假设队列中,接受基于培养的治疗策略的患者每增加10%,总成本将降低466美元。对于基于培养的治疗策略,根除成功率每提高10%,总成本降低24,058美元;对于经验性治疗策略,根除成功率每提高10%,总成本降低20,241美元。

结论

在治疗儿童感染患者方面,基于培养的治疗策略比经验性治疗策略更具成本效益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/beba7695700f/fped-10-860960-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/d6cc071cff2d/fped-10-860960-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/46fa582135ab/fped-10-860960-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/9c50634de6a7/fped-10-860960-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/beba7695700f/fped-10-860960-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/d6cc071cff2d/fped-10-860960-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/46fa582135ab/fped-10-860960-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/9c50634de6a7/fped-10-860960-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e226/9110685/beba7695700f/fped-10-860960-g0004.jpg

相似文献

1
A Culture-Based Strategy Is More Cost Effective Than an Empiric Therapy Strategy in Managing Pediatric Infection.在处理儿童感染方面,基于培养的策略比经验性治疗策略更具成本效益。
Front Pediatr. 2022 May 3;10:860960. doi: 10.3389/fped.2022.860960. eCollection 2022.
2
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.质子泵抑制剂治疗急性上消化道出血的临床疗效及成本效益的系统评价
Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. doi: 10.3310/hta11510.
3
Evaluation of the dyspeptic patient: a cost-utility study.消化不良患者的评估:一项成本效益研究。
J Fam Pract. 1997 Jun;44(6):545-55.
4
Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.疑似消化性溃疡疾病的即时内镜检查或初始幽门螺杆菌血清学检测:使用决策分析评估成本效益
Yale J Biol Med. 1996 Mar-Apr;69(2):187-95.
5
Review article: uninvestigated dyspepsia and non-ulcer dyspepsia-the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy.综述文章:未作检查的消化不良和非溃疡性消化不良——内镜检查的应用以及幽门螺杆菌根除和抑酸治疗的作用
Aliment Pharmacol Ther. 2004 Feb;19 Suppl 1:1-8. doi: 10.1111/j.0953-0673.2004.01829.x.
6
Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.对既往有消化性溃疡病史患者立即根除幽门螺杆菌:临床及经济影响
Am J Gastroenterol. 1997 Nov;92(11):2017-24.
7
Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.台湾南部儿童幽门螺杆菌感染中克拉霉素和甲硝唑耐药性的增加:二十年的对比。
Helicobacter. 2019 Oct;24(5):e12633. doi: 10.1111/hel.12633. Epub 2019 Jul 11.
8
Economic evaluation in gastrointestinal disease.胃肠疾病的经济学评估
Scand J Gastroenterol Suppl. 1996;220:44-51. doi: 10.3109/00365529609094749.
9
Alternative management strategies for patients with suspected peptic ulcer disease.疑似消化性溃疡疾病患者的替代管理策略。
Ann Intern Med. 1995 Aug 15;123(4):260-8. doi: 10.7326/0003-4819-123-4-199508150-00003.
10
Efficacy and cost-effectiveness of the 13C-urea breath test as the primary diagnostic investigation for the detection of Helicobacter pylori infection compared to invasive and non-invasive diagnostic tests.与侵入性和非侵入性诊断测试相比,13C-尿素呼气试验作为检测幽门螺杆菌感染的主要诊断检查的有效性和成本效益。
GMS Health Technol Assess. 2009 Oct 21;5:Doc14. doi: 10.3205/hta000076.

引用本文的文献

1
Therapeutic eradication choices in infection in children.儿童感染的治疗根除选择。
Therap Adv Gastroenterol. 2023 Apr 27;16:17562848231170052. doi: 10.1177/17562848231170052. eCollection 2023.

本文引用的文献

1
Review: Helicobacter pylori in pediatrics.综述:小儿幽门螺杆菌。
Helicobacter. 2019 Sep;24 Suppl 1:e12639. doi: 10.1111/hel.12639.
2
Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.台湾南部儿童幽门螺杆菌感染中克拉霉素和甲硝唑耐药性的增加:二十年的对比。
Helicobacter. 2019 Oct;24(5):e12633. doi: 10.1111/hel.12633. Epub 2019 Jul 11.
3
Helicobacter pylori Infection and Related Gastrointestinal Diseases in Southeast Asian Countries: An Expert Opinion Survey.
东南亚国家幽门螺杆菌感染及相关胃肠道疾病:一项专家意见调查
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3565-3569. doi: 10.31557/APJCP.2018.19.12.3565.
4
Helicobacter pylori antimicrobial resistance in a pediatric population.儿童人群中幽门螺杆菌的抗菌药物耐药性。
Helicobacter. 2018 Oct;23(5):e12528. doi: 10.1111/hel.12528. Epub 2018 Aug 9.
5
Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies.儿童患者的幽门螺杆菌感染:诊断和根除策略的最新进展。
Paediatr Drugs. 2018 Aug;20(4):337-351. doi: 10.1007/s40272-018-0296-y.
6
Sedation in Pediatric Esophagogastroduodenoscopy.小儿食管胃十二指肠镜检查中的镇静
Clin Endosc. 2018 Mar;51(2):120-128. doi: 10.5946/ce.2018.028. Epub 2018 Mar 30.
7
Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.抗药性与斯洛文尼亚儿童分离的幽门螺杆菌菌株中特定三联疗法的成功。
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12400. Epub 2017 Jun 27.
8
Review: Prevalence and dynamics of Helicobacter pylori infection during childhood.综述:儿童时期幽门螺杆菌感染的流行率和动态变化。
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12399. Epub 2017 Jun 23.
9
Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016).欧洲儿科胃肠病、肝病和营养学会/北美儿科胃肠病、肝病和营养学会儿童及青少年幽门螺杆菌管理联合指南(2016年更新版)
J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):991-1003. doi: 10.1097/MPG.0000000000001594.
10
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.全球幽门螺杆菌感染率:系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):420-429. doi: 10.1053/j.gastro.2017.04.022. Epub 2017 Apr 27.